These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 1734901)
1. Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update. Weinblatt ME; Weissman BN; Holdsworth DE; Fraser PA; Maier AL; Falchuk KR; Coblyn JS Arthritis Rheum; 1992 Feb; 35(2):129-37. PubMed ID: 1734901 [TBL] [Abstract][Full Text] [Related]
2. Longterm prospective study of methotrexate in rheumatoid arthritis: conclusion after 132 months of therapy. Weinblatt ME; Maier AL; Fraser PA; Coblyn JS J Rheumatol; 1998 Feb; 25(2):238-42. PubMed ID: 9489813 [TBL] [Abstract][Full Text] [Related]
3. Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months. Kremer JM; Phelps CT Arthritis Rheum; 1992 Feb; 35(2):138-45. PubMed ID: 1734902 [TBL] [Abstract][Full Text] [Related]
4. Methotrexate in rheumatoid arthritis. A five-year prospective multicenter study. Weinblatt ME; Kaplan H; Germain BF; Block S; Solomon SD; Merriman RC; Wolfe F; Wall B; Anderson L; Gall E Arthritis Rheum; 1994 Oct; 37(10):1492-8. PubMed ID: 7945475 [TBL] [Abstract][Full Text] [Related]
5. The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis. Kremer JM; Lee JK Arthritis Rheum; 1986 Jul; 29(7):822-31. PubMed ID: 3741499 [TBL] [Abstract][Full Text] [Related]
6. Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial. Bakker MF; Jacobs JW; Welsing PM; Verstappen SM; Tekstra J; Ton E; Geurts MA; van der Werf JH; van Albada-Kuipers GA; Jahangier-de Veen ZN; van der Veen MJ; Verhoef CM; Lafeber FP; Bijlsma JW; Ann Intern Med; 2012 Mar; 156(5):329-39. PubMed ID: 22393128 [TBL] [Abstract][Full Text] [Related]
7. A prospective study of the long-term efficacy and toxicity of low-dose methotrexate in rheumatoid arthritis. Salaffi F; Carotti M; Sartini A; Cervini C Clin Exp Rheumatol; 1995; 13(1):23-8. PubMed ID: 7774099 [TBL] [Abstract][Full Text] [Related]
9. Long-term treatment of destructive rheumatoid arthritis with methotrexate. Rau R; Schleusser B; Herborn G; Karger T J Rheumatol; 1997 Oct; 24(10):1881-9. PubMed ID: 9330927 [TBL] [Abstract][Full Text] [Related]
10. [The short-term efficacy and safety of methotrexate plus low dose prednisone in patients with rheumatoid arthritis]. Liu SY; Yang L; Zhang L; Zhang X; He YJ Zhonghua Nei Ke Za Zhi; 2013 Dec; 52(12):1018-22. PubMed ID: 24503398 [TBL] [Abstract][Full Text] [Related]
11. Methotrexate in rheumatoid arthritis: effects on disease activity in a multicenter prospective study. Weinblatt ME; Kaplan H; Germain BF; Merriman RC; Solomon SD; Wall B; Anderson L; Block S; Small R; Wolfe F J Rheumatol; 1991 Mar; 18(3):334-8. PubMed ID: 1856803 [TBL] [Abstract][Full Text] [Related]
12. Treatment continuation rate in relation to efficacy and toxicity in long-term therapy with low-dose methotrexate, sulfasalazine, and bucillamine in 1,358 Japanese patients with rheumatoid arthritis. Nagashima M; Matsuoka T; Saitoh K; Koyama T; Kikuchi O; Yoshino S Clin Exp Rheumatol; 2006; 24(3):260-7. PubMed ID: 16870092 [TBL] [Abstract][Full Text] [Related]
13. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy. Rau R; Schleusser B; Herborn G; Karger T J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088 [TBL] [Abstract][Full Text] [Related]
14. Association of methotrexate and corticosteroids in the treatment of patients with rheumatoid arthritis. Bologna C; Jorgensen C; Sany J Clin Exp Rheumatol; 1996; 14(4):401-6. PubMed ID: 8871839 [TBL] [Abstract][Full Text] [Related]
15. Abatacept plus methotrexate provides incremental clinical benefits versus methotrexate alone in methotrexate-naive patients with early rheumatoid arthritis who achieve radiographic nonprogression. Wells AF; Westhovens R; Reed DM; Fanti L; Becker JC; Covucci A; Keystone EC J Rheumatol; 2011 Nov; 38(11):2362-8. PubMed ID: 21885491 [TBL] [Abstract][Full Text] [Related]
16. Methotrexate dosage reduction in patients with rheumatoid arthritis beginning therapy with infliximab: the Infliximab Rheumatoid Arthritis Methotrexate Tapering (iRAMT) trial. Fleischmann RM; Cohen SB; Moreland LW; Schiff M; Mease PJ; Smith DB; Keenan G; Kremer JM; Curr Med Res Opin; 2005 Aug; 21(8):1181-90. PubMed ID: 16083527 [TBL] [Abstract][Full Text] [Related]
18. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate. Lertnawapan R; Chonprasertsuk S; Siramolpiwat S Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876 [TBL] [Abstract][Full Text] [Related]
19. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study. Smolen JS; Han C; Bala M; Maini RN; Kalden JR; van der Heijde D; Breedveld FC; Furst DE; Lipsky PE; Arthritis Rheum; 2005 Apr; 52(4):1020-30. PubMed ID: 15818697 [TBL] [Abstract][Full Text] [Related]
20. Cyclosporine A in the treatment of early rheumatoid arthritis. A prospective, randomized 24-month study. Drosos AA; Voulgari PV; Papadopoulos IA; Politi EN; Georgiou PE; Zikou AK Clin Exp Rheumatol; 1998; 16(6):695-701. PubMed ID: 9844762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]